How to build market preference in B2B
In the cutthroat world of B2B healthcare and pharma, are you merely generating leads, or are you engineering a market that consistently prefers your brand?
The Middle East and Africa pharma market is growing fast, and so is the competition. In this environment, the traditional B2B playbook is failing.
B2B buyers now conduct extensive self-directed research before ever engaging with a vendor1. If your commercial team is waiting for a lead form to be filled out before establishing authority, you have already lost. Here is how to stop chasing leads and start building market preference.
1. The evolving B2B buyer journey
The modern B2B buyer in healthcare, pharma and FMCG is highly educated and deeply sceptical. They do not want a sales pitch; they want strategic insight.
This shift necessitates a move from reactive lead capture to proactive market preference engineering. Brands must establish authority and trust early in the decision-making process. If you are not educating the buyer during their self-directed research phase, your competitor is.
2. Trust and credibility as the new currency
In highly regulated and risk-averse sectors like healthcare, trust is paramount. Buyers are not just evaluating your product; they are evaluating your compliance, your data security and your institutional credibility.
A common failure mode is treating compliance as a mere footnote instead of a central message. Brands must demonstrate unwavering credibility through transparent communication, adherence to regulatory standards and evidence-based storytelling to become a preferred partner.
3. Lead generation vs preference building
There is a fundamental difference between generating a lead and building preference. Lead generation focuses on immediate conversion, often resulting in a high volume of loosely qualified prospects that do not convert.
Market preference engineering aims for long-term brand loyalty and advocacy. It involves nurturing relationships, providing continuous value and becoming an indispensable resource. Focusing solely on lead quantity rather than lead quality is a fast track to a bloated CRM and a frustrated sales team.
The winning framework: the Buyer Enlightenment Strategy
To become the default choice in B2B healthcare, commercial teams must adopt a Buyer Enlightenment Strategy:
- Quality over quantity: prioritise well-qualified, sales-ready opportunities over a high volume of loosely qualified leads.
- Trust-centric messaging: ground all communications in facts, case studies and data-backed outcomes. Proactively address compliance.
- Account-based marketing (ABM): target high-value accounts with tailored messaging that resonates with their specific priorities, demonstrating genuine understanding of their business challenges.
Sources
- Gartner research on the B2B buying journey (first published by CEB): buyers spend about 17% of their buying time meeting potential suppliers. gartner.com